Relationships among Serum Adiponectin, Leptin and Vitamin D Concentrations and the Metabolic Syndrome in Farmers
Article information
Korean J Community Nutr. 2014;19(1):12-26
Publication date (electronic) : 2014 February 28
doi :
https://doi.org/10.5720/kjcn.2014.19.1.12
Received 2014 January 13; Revised 2014 February 14; Accepted 2014 February 18.
Abstract
The purpose of this study was to investigate the relationships among serum adiponectin, leptin and vitamin D concentrations and the metabolic syndrome in Korean farmers. 105 (26 males, 79 females) farmers (39~78 years, mean age 59.4 ± 9.6 years) in Gangwon - area were included in this study. Anthropometric measurements and biochemical blood analysis of subjects were carried out. The prevalence of obesity, abdominal obesity, hypertension, diabetes, hypertriglyceridemia, hypercholesterolemia and hyper LDL-cholesterolemia, metabolic syndrome were 51.9%, 65.7%, 49.5%, 15.3%, 17.3%, 13.5%, 11.5% and 40.9%, respectively. Serum adiponectin and leptin levels (8.90 µg/ml and 12.6 ng/ml) of females were significantly higher than those (6.49 µg/ml and 4.88 ng/ml) of males. But there was no significant difference in 25(OH)vitamin D concentration between males (15.4 ng/ml) and females (16.9 ng/ml). In the subjects with metabolic syndrome, the adiponectin levels were significantly lower and leptin levels were significantly higher than those of the subjects without metabolic syndrome. Serum adiponectin level had positive correlations with HDL-cholesterol level (r = 0.325, p < 0.001), but showed negative correlations with triglyceride and fasting blood glucose concentrations, body weight and waist/hip circumference ratio (r = -0.202 ~ -0.317, p < 0.05). Serum leptin and 25(OH)vitamin D concentrations were positively correlated with body fat (kg, %) and BMI, waist and hip circumferences (r = 0.244 ~ 0.682, p < 0.001). The results of this study suggested that adiponectin and leptin levels could be credible indices to predict chronic diseases in farmers. However, further research on vitamin D should be carried out considering another factors.
Keywords: farmer; adiponectin; leptin; vitamin D; chronic diseases
Notes
This study was supported by grants from rural development administration of Korea (RDA: 20120401-037-501-001-03-00).
References
1. Adamczak M, Wiecek A, Funahashi T, Chudek J, Kokot F, Matsuzawa Y. Decreased plasma adiponectin concentration in patients with essential hypertension. Am J Hypertens 2003;16(1):72–75.
2. Ahima RS, Flier JS. Adipose tissue as an endocrine organ. Trends Endocrinol Metab 2000;11(8):327–332.
3. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999;257(1):79–83.
4. Artaza JN, Mehrotra R, Norris KC. Vitamin D and cardiovascular system. Clin J Am Soc Nephrol 2009;4(9):1515–1522.
5. Boden G, Chen X, Kolaczynski JW, Polansky M. Effects of prolonged hyperinsulinemia on serum leptin in normal human subjects. J Clin Invest 1997;100(5):1107–1113.
6. Bruun JM, Lihn AS, Verdich C, Pedersen SB, Toubro S, Astrup A, Richelsen B. Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans. Am J Physiol Endocrinol Metab 2003;285(3):E527–E533.
7. Buettner C, Muse ED, Cheng A, Chen L, Scherer T, Pocai A. Leptin controls adipose tissue lipogenesis via central, STAT3-independent mechanisms. Nat Med 2008;14(6):667–675.
8. Cho YG, Kang JH. Clinical implications of the metabolic syndrome. Food Ind Nutr 2010;15(1):1–3.
9. Cho YH. Relationnship among Chronic Disease, Health Status and Health Related Lifestyle of Rural elderly by Gender. J Korean Soc Health Educ Promot 2009;26(2):35–47.
10. Choe JS, Paik HY, Kwon SO. Nutritional status and related factors of residents aged over 50 in longevity areas I. Anthropometric measurements and biochemical nutritional status. Korean J Nutr 2004;37(9):825–837.
11. Choi KM, Lee J, Lee KW, Seo JA, Oh JH, Kim SG, Kim NH, Choi DS, Baik SH. Serum adiponectin concentrations predict the developments of type 2 diabetes and the metabolic syndrome in elderly Koreans. Clin Endocrinol (Oxf) 2004;61(1):75–80.
12. Choi YJ, Chang MJ. Comparison of abdominal fat, Aaipocytokine, metabolic syndrome risk factors between diabetes group and none-diabetes group in individuals with spinal cord injury. J Adapt Phys Act Exerc 2010;18(3):57–70.
13. Cnop M, Havel PJ, Utzschneider KM, Carr DB, Sinha MK, Boyko EJ, Retzlaff BM, Knopp RH, Brunzell JD, Kahn SE. Relationship of adiponectin to body fat distribution, Iinsulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 2003;46(4):459–469.
14. Colston KW. Vitamin D and breast cancer risk. Best Pract Res Clin Endocrinol Metab 2008;22(4):587–599.
15. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL. Serum immunoreactive - leptin concentrations in normal-weight and obese humans. N Engl J Med 1996;334(5):292–295.
16. Du Bois D, Du Bois EF. A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 1916;17:863–871.
17. Mathieu C, Van der Schueren BJ. Vitamin D deficiency is not good for you. Diabetes Care 2011;34(5):1245–1246.
18. Fasshauer M, Paschke R. Regulation of adipocytokines and insulin resistance. Diabetologia 2003;46(12):1594–1603.
19. Ford ES, Ajani UA, McGuire LC, Liu S. Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabetes Care 2005;28(5):1228–1230.
20. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499–502.
21. Fruhbeck G, Nutr R, Salvador L. Role of adipocytokines in metabolism and disease. Nutr Res 2004;24(10):803–826.
22. Gannage-Yared MH, Chedid R, Khalife S, Azzi E, Zoghbi F, Halaby G. Vitamin D in relation to metabolic risk factors, insulin sensitivity and adiponectin in a young middle-eastern population. Eur J Endocrinol 2009;160(6):965–971.
23. Heo KH, Won YL, Ko KS, Kim KW. Effects of obesity on the physiological levels of adiponectin, leptin and diagnostic indices of metabolic syndrome in male workers. Korean J Occup Health Nurs 2009;18(1):44–54.
24. Hercberg S, Galan P, Preziosi P, Bertrais S, Mennen L, Malvy D, Roussel AM, Favier A, Briancon S. The SU.VI.MAX Study: A randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch Intern Med 2004;164(21):2335–2342.
25. Heymsfield SB, McManus CB, Smith J, Stevens V, Nixon DW. Anthropometric measurement of muscle mass, revised equations for calculating bone-free arm muscle area. Am J Clin Nutr 1982;36(4):680–690.
26. Hjelmesaeth J, Hofso D, Aasheim ET, Jenssen T, Moan J, Hager H, Roislien J, Bollerslev J. Parathyroid hormone, but not vitamin D, is associated with the metabolic syndrome in morbidly obese women and men: a cross-sectional study. Cardiovasc Diabetol 2009;8:7.
27. Holick MF. Vitamin D deficiency. N Engl J Med 2007;357(3):266–281.
28. Hong KP, Kho SH. Diagnosis and drug therapy of hypertension. Diagnosis and drug therapy of hypertension. J Korean Acad Fam Med 1992;13(6):484–490.
29. Hwang YC, Jee JH, Oh EY, Choi YH, Lee MS, Kim KW, Lee MK. Metabolic syndrome as a predictor of cardiovascular diseases and type 2 diabetes in Koreans. Int J Cardiol 2009;134(3):313–321.
30. Hypponen E, Power C. Vitamin D status and glucose homeostasis in the 1958 British birth cohort: the role of obesity. Diabetes Care 2006;29(10):2244–2246.
31. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. JAMA 2001;285:2486–2497.
32. Khader YS, Batieha A, Jaddou H, Batieha Z, El-Khateeb M, Ajlouni K. Relationship between 25-Hydroxyvitamin D and metabolic syndrome among Jordanian adults. Nutr Res Pract 2011;5(2):132–139.
33. Kim DL, Kim NH, Shin DH, Kim SG, Choi KM, Kim JK, Shin C, Lee SG. Plasma leptin concentration, obesity, and insulin resistance in healthy Korean population. J Korean Diabetes Assoc 2002;26:100–111.
34. Kim JI, Kang MJ. Recent consumption and physiological status of vitamin D in Korean population. Food Ind Nutr 2012;17(2):7–10.
35. Kim KJ, Park JS, Ahn NY, Chun WK, Hong CB, Kim EJ, Park SE, Kang SH, Lee SJ. Blood concentrations of lipid profiles and leptin, bone density, and abdominal fat in adult women. Korean J Exerc Nutr 2003;7(3):271–276.
36. Kim MJ, Jun HY, Rha HB. Comparison of serum adiponectin levels according to body mass index and dietary behaviors of female university students in Seoul. Korean J Community Nutr 2013;18(4):354–364.
37. Kim MK, Il Kang M, Won Oh K, Kwon HS, Lee JH, Lee WC, Yoon KH, Son HY. The association of serum vitamin D level with presence of metabolic syndrome and hypertension in middle-aged Korean subjects. Clin Endocrinol (Oxf) 2010;73(3):330–338.
38. Kim SJ, Park KG, Kim HK, Kim MK, Lee SW, Hwang JS, Han SW, Hur SH, Lee IK. Serum adiponectin concentration according to visceral fat amount and its relationship of metabolic risk factors in premenopausal obese women. Korean J Med 2004;66(3):259–266.
39. Kim YJ, Moon MS, Yang YJ, Kwon OR. Relationship between serum 25-hydroxyvitamin D concentration and the risks of metabolic syndrome in premenopausal and postmenopausal women. Korean J Nutr 2012;45(1):20–29.
40. Koh SB, Park JK, Yoon JH, Chang SJ, Oh SS, Kim JY, Ryu SY, Kim KS, Lee TY, You JS. Preliminary report: A serious link between adiponectin levels and metabolic syndrome in a Korean nondiabetic population. Metabolism 2010;59(3):333–337.
41. Kolaczynski JW, Nyce MR, Considine RV, Boden G, Nolan JJ, Henry R, Mudaliar SR, Olefsky J, Caro JF. Acute and chronic effects of insulin on leptin production in humans: studies in vivo and in vitro. Diabetes 1996;45(5):699–701.
42. Korean National Statistical Office. Agriculture, Foresty and Fisheries Research Report 2012 2012.
43. Korean National Statistical Office. The statistics of mortality and the causes 2012. cited 2013 September 25. Available from http://www.kostat.go.kr.
44. Krakoff J, Funahashi T, Stehouwer CD, Schalkwijk CG, Tanaka S, Matsuzawa Y, Kobes S, Tataranni PA, Hanson RL, Knowler WC, Lindsay RS. Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian. Diabetes Care 2003;26(6):1745–1751.
45. Kumada M, Kihara S, Sumitsuji S, Kawamoto T, Matsumoto S, Ouchi N, Arita Y, Okamoto Y, Shimomura I, Hiraoka H, Nakamura T, Funahashi T, Matsuzawa Y. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 2003;23(1):85–89.
46. Lee EJ, Kim KR, Song YD, Lee HC, Huh KB, Chung CH, Lim SK, Chung YS. Seasonal variation in serum 25-Hydroxyvitamin D in the elderly in Korean. J Korean Soc Endocrinol 1994;9(2):121–127.
47. Lee HC. Estimating optimum level of population in rural areas based on rural population forecasts and over-depopulation classification schemes. Korean J Rural Tourism 2007;14(1):159–181.
48. Lee HS, Kwun IS, Kwon CS. Anthropometric measurements and biochemical nutritional status of the older residents (50 years and over) in Andong area II. J Korean Soc Food Sci Nutr 2008;37(12):1599–1608.
49. Lee JH, Hong JH, Kim HJ, Park KS, Lee JM, Kim BJ, Ahn KJ, Jeong BO, Kim SH, Lee SK. A study on the relationship of serum Vitamin D levels with insulin resistance in premenopausal women. J East Asian Soc Diet Life 2009;19(5):713–722.
50. Lee MS, Woo MK. A study of health-related habits, dietary behaviors and the health status of the middle-aged and the elderly living in the Chonju Area(II). Korean J Community Nutr 2002;7(6):749–761.
51. Lee MY, Kim JH. Comparison of serum insulin, leptin, adiponectin and high sensitivity c-reactive protein levels according to body mass index and their associations in adult women. Korean J Community Nutr 2011;16(1):126–135.
52. Lee SE, Moon JH, Ahn JH, Oh YS, Shin SH. The association between plasma adiponectin and the components of metabolic syndrome in adults with abdominal obesity. Korean J Obes 2007;16(4):147–153.
53. Lim WJ, Yoon JS. A longitudinal study on seasonal variations of physical activity and body composition of rural women. Korean J Nutr 1995;28(9):893–903.
54. Lindsay RS, Funahashi T, Hanson RL, Matsuzawa Y, Tanaka S, Tataranni PA, Knowler WC, Krakoff J. Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 2002;360(9326):57–58.
55. Lips P, Hosking D, Lippuner K, Norquist JM, Wehren L, Maalouf G, Ragi-Eis S, Chandler J. The prevalence of Vitamin D inadequacy amongst women with osteoporosis: An international epidemiological investigation. J Intern Med 2006;260(3):245–254.
56. Lu L, Yu Z, Pan A, Hu FB, Franco OH, Li H, Li X, Yang X, Chen Y, Lin X. Plasma 25-Hydroxyvitamin D concentration and metabolic syndrome among middle-aged and elderly Chinese individuals. Diabetes Care 2009;32(7):1278–1283.
57. Malabanan A, Veronikis IE, Holick MF. Redefining vitamin D insufficiency. Lancet 1998;351(9105):805–806.
58. Mallamaci F, Zoccali C, Cuzzola F, Tripepi G, Cutrupi S, Parlongo S, Tanaka S, Ouchi N, Kihara S, Funahashi T, Matsuzawa Y. Adiponectin in essential hypertension. J Nephrol 2002;15(5):507–511.
59. Martins D, Wolf M, Pan D, Zadshir A, Tareen NM, Felsenfeld A, Levine B, Mechrotra R, Norris K. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 2007;167(11):1159–1165.
60. Matsuzawa Y, Funahashi T, Kihara S, Shimomura I. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 2004;24(1):29–33.
61. McKenna MJ. Differences in vitamin D status between countries in young adults and the elderly. AM J Med 1992;93(1):69–77.
62. McNeill AM, Rosamond WD, Girman CK, Golden SH, Schmidt ML, East HE. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities Study. Diabetes Care 2005;28(2):385–390.
63. Michos ED, Melamed ML. Vitamin D and cardiovascular disease risk. Curr Opin Clin Nutr Metab Care 2008;11:7–12.
64. Ministry of Health and Welfare. Korea Health Statistics 2010. Korea National Health and Nutrition Examination Survey (KNHANES -1) 2011.
65. Mojiminiyi OA, Abdella NA, Arouj MA, Nakhi AB. Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with type 2 diabetes. Int J Obes (Lond) 2007;31(2):213–220.
66. Motoshima H, Wu X, Sinha MK, Hardy VE, Rosato EL, Barbot DJ, Rosato FE, Goldstein BJ. Differential regulation of adiponectin secretion from cultured human omental and subcutaneous adipocytes: effects of insulin and rosiglitazone. J Clin Endocrinol Metab 2002;87(12):5662–5667.
67. Muoio DM, Dohm GL. Peripheral metabolic actions of leptin. Best Pract Res Clin Endocrinol Metab 2002;16(4):653–666.
68. Nagy TR, Gower BA, Trowbridge CA, Dezenberg C, Shewchuk RM, Goran MI. Effects of gender, ethnicity, body composition, and fat distribution on serum leptin concentrations in children. J Clin Endocrinol Metab 1997;82(7):2148–2152.
69. NCEP. Third report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults 2001.
70. Nishizawa H, Shimomura I, Kishida K, Maeda N, Kuriyama H, Nagaretani H, Matsuda M, Kondo H, Furuyama N, Kihara S, Nakamura T, Tochino Y, Funahashi T, Matsuzawa Y. Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes 2002;51(9):2734–2741.
71. Oda N, Imamura S, Fujita T, Uchida Y, Inagaki K, Kakizawa H, Hayakawa N, Suzuki A, Takeda J, Horikawa Y, Itoh M. The ratio of leptin to adiponectin can be used as an index of insulin resistance. Metab Clin Exp 2008;57(2):268–273.
72. Oh JY, Hong YS, Sung YA. Association between hyperleptinemia and metabolic syndrome in an urban korean community. J Korean Diabetes Assoc 2003;27(4):313–322.
73. Ohashi K, Kihara S, Ouchi N, Kumada M, Fujita K, Hiuge A, Hibuse T, Ryo M, Nishizawa H, Maeda N, Maeda K, Shibata R, Walsh K, Funahashi T, Shimomura I. Adiponectin replenishment ameliorates obesity-related hypertension. Hypertension 2006;47(6):1108–1116.
74. Oosterwerff MM, Eekhoff EM, Heymans MW, Lips P, van Schoor NM. Serum 25-hydroxyvitamin D levels and the metabolic syndrome in older persons: a population-based study. Clin Endocrinol (Oxf) 2011;75(5):608–613.
75. Paolisso G, Rizzo MR, Mone CM, Tagliamonte MR, Gambardella A, Riondino M, Carella C, Varricchio M, D'Onofrio F. Plasma sex hormones are significantly associated with plasma leptin concentration in healthy subjects. Clin Endocrinol (Oxf) 1998;48(3):291–297.
76. Park HA, Kim SY. Recent advance on vitamin D. J Korean Med Assoc 2013;56(4):310–318.
77. Park Y. Vitamin D and atopic dermatitis. Allergy Asthma Respir Dis 2013;1(3):197–202.
78. Reaven GM. Do high carbohydrate diets prevent the development or attenuate the manifestations (or both) of syndrome X? A viewpoint strongly against. Curr Opin Lipidol 1988;8(1):23–27.
79. Ruige JB, Deckker JM, Blum WF, Stehouwer CD, Nijpels G, Mooy J, Kostense PJ, Bouter LM, Heine RJ. Leptin and variables of body adiposity, energy balance, and insulin resistance in a population-based study. The Hoorn Study. Diabetes Care 1999;22(7):1097–1104.
80. Ryan AS, Berman DM, Nicklas BJ, Sinha M, Gingerich RL, Meneilly GS, Egan JM, Elahi D. Plasma adiponectin and leptin levels, body composition, and glucose utilization in adult women with wide ranges of age and obesity. Diabetes Care 2003;26(8):2383–2388.
81. Ryo M, Nakamura T, Kihara S, Kumada M, Shibazaki S, Takahashi M, Nagaii M, Matsuzawa Y, Funahashi T. Adiponectin as a biomarker of the metabolic syndrome. Circ J 2004;68(11):975–981.
82. Ryu ST, Park SO, Kim SH. The relation of serum adiponectin and resistin concentrations with metabolic risk factors. J Korean Soc Endocrinol 2005;20(5):444–451.
83. Satoh N, Naruse M, Usui T, Tagami T, Suganami T, Yamada K, Kuzuya H, Shimatsu A, Ogawa Y. Leptin-to-adiponectin ratio as a potential atherogenic index in obese type 2 diabetic patients. Diabetes Care 2004;27(10):2488–2490.
84. Scragg R, Sowers M, Bell C. Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey. Am J Hypertens 2007;20(7):713–719.
85. Segal K, Landt M, Klein S. Relationship between insulin sensitivity and plasma leptin concentration in lean and obese men. Diabetes 1996;45(7):988–991.
86. Shim WS, Kim HJ, Kang ES, Rhee YM, Ahn CW, Lim SK, Lee HC, Cha BS. The relationship between the leptin concentration and the small dense low density lipoprotein cholesterol concentration in Korean type 2 diabetic patients. J Korean Soc Endocrinol 2006;21(4):319–327.
87. Shin MY, Kwun IS. Vitamin D: Is it a vitamin or a hormone? Food Ind Nutr 2012;17(2):1–6.
88. Suh MK. Health states of the eldery and policy implications. J Korea Gerontol Soc 1995;15(1):28–39.
89. Tilg H, Monschen AR. Adipocyto-kines: Mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006;6:772–783.
90. Tsou PL, Jiang YD, Chang CC, Wei JN, Sung FC, Lin CC, Chiang CC, Tai TY, Chuang LM. Sex-related differences between adiponectin and insulin resistance in schoolchildren. Diabetes Care 2004;27(2):308–313.
91. Wannamethee SG, Shaper AG, Lennon L, Morris RW. Metabolic syndrome vs Framinham Risk Score for predication of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch Intern Med 2005;165(22):2644–2650.
92. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001;86(5):1930–1935.
93. World Health Organization. Obesity. Preventing and managing the global epidemic : Report of a WHO Consultation on Obesity Geneva: 1998.
94. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, Eto K, Akanuma Y, Froguel P, Foufelle F, Ferre P, Carling D, Kimura S, Nagai R, Kahn BB, Kadowaki T. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 2002;8:1288–1295.
95. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001;7:941–946.
96. Yoo KH, Oh IM, Park JE, Park JS, Park SJ, Jang EJ, Park SW, Kim SJ, Yoon YS, Joung HJ, Baik HW. Metabolic syndrome is associated with low adiponectin level and increased insulin resistance in apparently healthy Koreans. Korean J Obes 2012;21(3):175–182.
97. Yoon SJ, Lee SW, Tun JE, Kim SY, Cho ER, Lee SJ, Jee EJ, Lee HY, Park JY, Kim HS, Jee SH. The association between adiponectin and diabetes in the Korean population. Metabolism 2008;57:853–857.
98. Zhuo Q, Wang Z, Fu P, Piao J, Tian Y, Xu J, Yang X. Comparison of adiponectin, leptin and leptin to adiponectin ratio as diagnostic marker for metabolic syndrome in older adults of Chinese major cities. Diabetes Res Clin Pract 2009;84(1):27–33.
99. Zoccali C, Mallamaci F, Tripepi G, Benedetto FA, Cutrupi S, Parlongo S, Malatino LS, Bonanno G, Seminara G, Rapisarda F, Fatuzzo P, Buemi M, Nicocia G, Tanaka S, Ouchi N, Kihara S, Funahashi T, Matsuzawa Y. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol 2002;13(1):134–141.
Article information Continued
Copyright © 2014 The Korean Society of Community Nutrition
Funded by : Grants from rural development administration of Korea
Award ID : RDA: 20120401-037-501-001-03-00
